TRPML1 maintains oncogenic mutations in the RAS family by mediating cholesterol de-esterification and transport, and reducing the proliferation of cancer cells that express oncogenic mutations by TRPML1 inhibition [151,152]. The gene discussed is MCOLN1; the disease is cancer.